Your browser doesn't support javascript.
loading
A novel role for flotillin-1 in H-Ras-regulated breast cancer aggressiveness.
Koh, Minsoo; Yong, Hae-Young; Kim, Eun-Sook; Son, Hwajin; Jeon, You Rim; Hwang, Jin-Sun; Kim, Myeong-Ok; Cha, Yujin; Choi, Wahn Soo; Noh, Dong-Young; Lee, Kyung-Min; Kim, Ki-Bum; Lee, Jae-Seon; Kim, Hyung Joon; Kim, Haemin; Kim, Hong-Hee; Kim, Eun Joo; Park, So Yeon; Kim, Hoe Suk; Moon, Woo Kyung; Choi Kim, Hyeong-Reh; Moon, Aree.
Affiliation
  • Koh M; College of Pharmacy, Duksung Women's University, Seoul, Korea.
  • Yong HY; College of Pharmacy, Duksung Women's University, Seoul, Korea.
  • Kim ES; College of Pharmacy, Duksung Women's University, Seoul, Korea.
  • Son H; College of Pharmacy, Duksung Women's University, Seoul, Korea.
  • Jeon YR; College of Pharmacy, Duksung Women's University, Seoul, Korea.
  • Hwang JS; College of Pharmacy, Duksung Women's University, Seoul, Korea.
  • Kim MO; College of Pharmacy, Duksung Women's University, Seoul, Korea.
  • Cha Y; College of Pharmacy, Duksung Women's University, Seoul, Korea.
  • Choi WS; Department of Immunology, School of Medicine, Konkuk University, Chungju, Korea.
  • Noh DY; Department of Surgery and Cancer Research Institute, College of Medicine, Seoul National University, Seoul, Korea.
  • Lee KM; Department of Surgery and Cancer Research Institute, College of Medicine, Seoul National University, Seoul, Korea.
  • Kim KB; Department of Molecular Medicine, College of Medicine, Inha University, Incheon, Korea.
  • Lee JS; Department of Molecular Medicine, College of Medicine, Inha University, Incheon, Korea.
  • Kim HJ; Department of Oral Physiology, School of Dentistry, Pusan National University, Yangsan, Korea.
  • Kim H; Department of Cell and Developmental Biology, BK21 Program and Dental Research Institute, Seoul National University, Seoul, Korea.
  • Kim HH; Department of Cell and Developmental Biology, BK21 Program and Dental Research Institute, Seoul National University, Seoul, Korea.
  • Kim EJ; Department of Pathology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
  • Park SY; Department of Pathology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
  • Kim HS; Department of Radiology, Seoul National University Hospital, Seoul, Korea.
  • Moon WK; Department of Radiology, Seoul National University Hospital, Seoul, Korea.
  • Choi Kim HR; Department of Pathology, Wayne State University School of Medicine, Detroit, MI.
  • Moon A; College of Pharmacy, Duksung Women's University, Seoul, Korea.
Int J Cancer ; 138(5): 1232-45, 2016 Mar 01.
Article in En | MEDLINE | ID: mdl-26413934
ABSTRACT
Elevated expression and aberrant activation of Ras have been implicated in breast cancer aggressiveness. H-Ras, but not N-Ras, induces breast cell invasion. A crucial link between lipid rafts and H-Ras function has been suggested. This study sought to identify the lipid raft protein(s) responsible for H-Ras-induced tumorigenicity and invasiveness of breast cancer. We conducted a comparative proteomic analysis of lipid raft proteins from invasive MCF10A human breast epithelial cells engineered to express active H-Ras and non-invasive cells expressing active N-Ras. Here, we identified a lipid raft protein flotillin-1 as an important regulator of H-Ras activation and breast cell invasion. Flotillin-1 was required for epidermal growth factor-induced activation of H-Ras, but not that of N-Ras, in MDA-MB-231 triple-negative breast cancer (TNBC) cells. Flotillin-1 knockdown inhibited the invasiveness of MDA-MB-231 and Hs578T TNBC cells in vitro and in vivo. In xenograft mouse tumor models of these TNBC cell lines, we showed that flotillin-1 played a critical role in tumor growth. Using human breast cancer samples, we provided clinical evidence for the metastatic potential of flotillin-1. Membrane staining of flotillin-1 was positively correlated with metastatic spread (p = 0.013) and inversely correlated with patient disease-free survival rates (p = 0.005). Expression of flotillin-1 was associated with H-Ras in breast cancer, especially in TNBC (p < 0.001). Our findings provide insight into the molecular basis of Ras isoform-specific interplay with flotillin-1, leading to tumorigenicity and aggressiveness of breast cancer.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Genes, ras / Membrane Proteins Type of study: Prognostic_studies Limits: Adult / Aged / Animals / Female / Humans / Middle aged Language: En Year: 2016 Type: Article

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Genes, ras / Membrane Proteins Type of study: Prognostic_studies Limits: Adult / Aged / Animals / Female / Humans / Middle aged Language: En Year: 2016 Type: Article